Campbell & Co. Investment Adviser »

Nurix Therapeutics shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2024-03-31 $762k 52k 14.70

More positions owned by Campbell & Co. Investment Adviser

United Rentals Common Stock (URI)
Parker-Hannifin Corp Common Stock (PH)
TE Connectivity Common Stock (TEL)
Nov Common Stock (NOV)
Revvity Common Stock (RVTY)
DuPont de Nemours Common Stock (DD)
Credit Acceptance Corp Common Stock (CACC)
State Street Corp Common Stock (STT)
Franklin Resources Common Stock (BEN)
Chubb Common Stock (CB)
McKesson Corp Common Stock (MCK)
Cheniere Energy Common Stock (LNG)
Idacorp Common Stock (IDA)
Jack Henry & Associates Common Stock (JKHY)
Nordson Corp Common Stock (NDSN)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Nurix Therapeutics

BlackRock
Redmile Group
Baker Bros. Advisors
ARK Investment Management
Vanguard Group
Morgan Stanley
T. Rowe Price Associates
Deutsche Bank Aktiengesellschaft
Daniel D. Thurber
Bain Capital Life Sciences Investors
Soleus Capital Management
Geode Capital Management
Dimensional Fund Advisors
Candriam Luxembourg S.C.A.
Pictet Asset Management Holding SA

View all funds holding Nurix Therapeutics